Private Advisor Group
MDCX icon

Private Advisor Group’s Medicus Pharma MDCX Stock Holding History

Private Advisor Group’s Portfolio MDCX Stock Details MDCX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-4,801
Closed -$110K – 2952
2026
Q1 		$110K Buy
4,801
+1,291
+37% +$67.4K ﹤0.01% 2522
2025
Q4 		$269K Buy
3,510
+480
+16% +$51.4K ﹤0.01% 2226
2025
Q3 		$351K Buy
3,030
+110
+4% +$13.8K ﹤0.01% 1980
2025
Q2 		$437K Buy
2,920
+1,785
+157% +$356K ﹤0.01% 1754
2025
Q1 		$211K Buy
+1,135
New +$178K ﹤0.01% 2076

Other funds holding MDCX

Interchange Capital Partners
Interchange Capital Partners Pittsburgh, Pennsylvania $532M AUM 26.57% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
XTX Topco
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
Sterling Investment Advisors (Pennsylvania)
Sterling Investment Advisors (Pennsylvania) Berwyn, Pennsylvania $599M AUM 28.66% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
May Hill Capital
May Hill Capital Cohasset, Massachusetts $479M AUM 31.88% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wilmington Savings Fund Society
Wilmington Savings Fund Society Wilmington, Delaware $4.48B AUM 24.77% 1-Year Est. Return

Private Advisor Group's MDCX Position: Q2 2026 in Review

Private Advisor Group sold out of Medicus Pharma (MDCX) in Q2 2026, closing a stake of 4,801 shares — an estimated $110K sold.

Private Advisor Group first reported a position in MDCX in Q1 2025 and held it in 5 quarters. The position peaked at $437K in Q2 2025. 23 funds tracked by Wall St. Rank hold MDCX as of Q2 2026.

  • Private Advisor Group reported no remaining Medicus Pharma position as of Q2 2026 after selling out during the quarter.
  • Private Advisor Group sold 4,801 Medicus Pharma shares in Q2 2026, an estimated $110K.
  • Private Advisor Group first reported a position in Medicus Pharma in Q1 2025 and held it in 5 quarters.
  • Private Advisor Group's Medicus Pharma position peaked at $437K in Q2 2025.
  • 23 funds tracked by Wall St. Rank held Medicus Pharma as of Q2 2026.

Based on Private Advisor Group's 13F filing for Q2 2026, filed 27 Jul 2026.